Legato Capital Management LLC Takes $688,000 Position in Astrana Health, Inc. $ASTH

Legato Capital Management LLC purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 27,739 shares of the company’s stock, valued at approximately $688,000.

A number of other large investors also recently modified their holdings of ASTH. Ameriprise Financial Inc. increased its holdings in shares of Astrana Health by 231.0% during the third quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock valued at $12,540,000 after purchasing an additional 308,665 shares during the period. 325 Capital LLC increased its holdings in shares of Astrana Health by 34.6% during the third quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock valued at $33,849,000 after purchasing an additional 307,037 shares during the period. Insight Wealth Strategies LLC acquired a new position in shares of Astrana Health during the fourth quarter valued at $3,514,000. Hotchkis & Wiley Capital Management LLC increased its holdings in shares of Astrana Health by 44.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 421,710 shares of the company’s stock valued at $11,955,000 after purchasing an additional 129,270 shares during the period. Finally, AXA S.A. acquired a new position in shares of Astrana Health during the second quarter valued at $3,150,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Price Performance

NASDAQ:ASTH opened at $38.54 on Wednesday. The business’s 50-day moving average price is $31.28 and its 200 day moving average price is $26.19. The firm has a market cap of $2.15 billion, a P/E ratio of 63.18 and a beta of 0.98. Astrana Health, Inc. has a 52-week low of $18.08 and a 52-week high of $39.93. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The firm had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.Astrana Health’s revenue was up 55.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.42 earnings per share. As a group, sell-side analysts predict that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ASTH has been the topic of a number of research analyst reports. Barclays raised Astrana Health from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $37.00 to $50.00 in a report on Tuesday. Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. Zacks Research raised Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. BTIG Research lifted their target price on Astrana Health from $40.00 to $50.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Finally, Weiss Ratings raised Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astrana Health presently has a consensus rating of “Moderate Buy” and an average price target of $45.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.